Ketogenic Diet and Breast Cancer: What the Research Says- The ketogenic diet (often called the “keto diet”) is a high-fat, very low-carbohydrate eating plan designed to shift the body into a metabolic state called ketosis, where fat is used for energy instead of glucose.
Because many cancer cells rely heavily on glucose to fuel growth, researchers have explored whether lowering blood sugar and insulin through a ketogenic diet might help slow tumor growth or improve treatment response.
For people diagnosed with breast cancer, the ketogenic diet is still considered experimental, but a growing body of research is exploring its potential benefits and risks.
There is an ongoing debate about the cancer patient’s diet as a possible complementary therapy to whatever conventional therapies the patient is also undergoing. Does diet matter? If so, which diet?
As a long-term cancer survivor, my meaning of the question, “does it matter?” means several things. First and foremost, when I ask if a diet matters when talking about surviving cancer, I mean does the cancer patient live longer, on average, when living on the diet in question? Secondly, does the diet supply the patient with the necessary protein, carbs, fiber, etc? And lastly, is the diet clean aka without pesticides, etc.
Below are three diets that are often included in the diet debate among cancer patients.
The study linked below finds that, on average, cancer patients live longer when living on a ketogenic diet. I linked the video below because Dr. Tom Seyfried talks about the same concepts that the study below does.
To complicate things a bit, I have often posted on PeopleBeatingCancer.org about the gut microbiome and its effect on chemotherapies and immunotherapy. I don’t know what a ketogenic diet does to the cancer patient’s gut microbiome.
Further, please pay strict attention to the study below when it states:
“However, long-term adherence showed large differences, with dropout rates ranging from 20% to over 50% in some trials. Factors contributing to non-adherence to ketogenic diets included taste fatigue, gastrointestinal symptoms such as nausea and constipation, and the restrictive nature of dietary protocols.”
As almost every dieter knows, sticking to any diet can be difficult. Be honest with yourself about your ability to stick to the rigors of a ketogenic diet before you begin. If your goal is to enhance the efficacy of treatment while reducing treatment side effects, consider learning more about:
This is just me but if I were a newly diagnosed cancer patient about to undergo induction therapy of some kind, I would focus on prehabilitation. I would find a local clinic to administer intravenous vitamin C therapy to me, I would exercise each day moderately, get plenty of sleep, and eat a diet shown to enhance my gut microbiome. Because chemotherapy and antibiotics have been shown to disrupt the gut microbiome, I would work to eat yogurt, fruits and veggies, etc., regularly. I might even snack a bit on dark chocolate.
Please scroll down the page and post a question or comment. I will reply to you ASAP.
Breast cancer cells often show altered metabolism, sometimes called the “Warburg effect.” These cancer cells rely heavily on glucose for energy.
A ketogenic diet dramatically reduces carbohydrate intake, which may:
Some researchers believe these changes may create conditions that are less favorable for cancer growth.
Preclinical research has shown that ketogenic diets may slow tumor growth, delay tumor development, and extend survival in animal models.
Clinical studies are still small, but several have explored how ketogenic diets affect breast cancer patients.
A randomized controlled trial examined ketogenic metabolic therapy in women with locally advanced or metastatic breast cancer undergoing chemotherapy.
Researchers found that patients on the ketogenic diet experienced:
The authors concluded the ketogenic diet may improve metabolic and inflammatory markers and potentially support treatment response, although more research is needed.
https://pubmed.ncbi.nlm.nih.gov/32703721/
An early clinical trial is exploring whether a ketogenic diet combined with the drug letrozole may improve outcomes for estrogen-receptor positive breast cancer.
Researchers hypothesize that reducing insulin and metabolic signaling may help slow cancer growth.
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2019-03071
Laboratory research suggests ketogenic diets may enhance response to certain targeted therapies such as Fulvestrant in metastatic breast cancer.
This suggests ketogenic metabolic changes might make tumors more vulnerable to treatment.
Some proposed benefits of ketogenic metabolic therapy include:
High insulin levels are associated with worse outcomes in several cancers. Keto diets can significantly reduce insulin levels.
Clinical studies show decreases in inflammatory markers in breast cancer patients following ketogenic diets.
Metabolic changes may make tumor cells more sensitive to chemotherapy, endocrine therapy, or targeted therapy.
Obesity and metabolic syndrome increase breast cancer risk and recurrence risk.
Ketogenic diets often produce rapid weight loss and improved metabolic markers, which may benefit some patients.
While some evidence is promising, ketogenic diets are not universally beneficial for all cancers.
Research suggests high levels of circulating fatty acids may promote tumor growth in some breast cancers.
A mouse study reported increased lung metastases in breast cancer models fed ketogenic diets.
Strict ketogenic diets can be low in:
These nutrients are often abundant in plant-rich anti-cancer diets.
The ketogenic diet remains a promising but experimental metabolic therapy in breast cancer.
Current evidence suggests it may:
However:
Most oncology researchers recommend using ketogenic diets only under medical supervision, ideally within clinical trials or integrative oncology programs.
To Learn More About Complementary Therapies